DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,241 filers reported holding DANAHER CORPORATION in Q2 2018. The put-call ratio across all filers is 0.63 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,135,149 | +3.1% | 8,606 | -0.2% | 1.57% | +1.4% |
| Q2 2023 | $2,070,240 | +2.9% | 8,626 | +8.1% | 1.55% | +4.0% |
| Q1 2023 | $2,011,783 | -4.7% | 7,982 | +0.4% | 1.49% | -21.9% |
| Q4 2022 | $2,110,089 | +7.3% | 7,950 | +4.5% | 1.91% | +9.4% |
| Q3 2022 | $1,966,000 | -47.7% | 7,610 | -48.7% | 1.75% | -39.8% |
| Q2 2022 | $3,761,000 | +1633.2% | 14,835 | +644.0% | 2.90% | +2240.3% |
| Q3 2018 | $217,000 | +10.2% | 1,994 | 0.0% | 0.12% | +4.2% |
| Q2 2018 | $197,000 | -65.9% | 1,994 | -66.2% | 0.12% | -60.7% |
| Q1 2018 | $578,000 | -4.5% | 5,907 | -9.4% | 0.30% | +2.7% |
| Q4 2017 | $605,000 | -48.7% | 6,520 | -52.6% | 0.30% | -15.2% |
| Q3 2017 | $1,180,000 | +2260.0% | 13,754 | +2200.0% | 0.35% | +1238.5% |
| Q2 2017 | $50,000 | -2.0% | 598 | 0.0% | 0.03% | -10.3% |
| Q1 2017 | $51,000 | +121.7% | 598 | +100.7% | 0.03% | +107.1% |
| Q4 2016 | $23,000 | +228.6% | 298 | +242.5% | 0.01% | +250.0% |
| Q3 2016 | $7,000 | -22.2% | 87 | 0.0% | 0.00% | -20.0% |
| Q2 2016 | $9,000 | -59.1% | 87 | -63.3% | 0.01% | -61.5% |
| Q1 2016 | $22,000 | 0.0% | 237 | 0.0% | 0.01% | +8.3% |
| Q4 2015 | $22,000 | +10.0% | 237 | 0.0% | 0.01% | +9.1% |
| Q3 2015 | $20,000 | 0.0% | 237 | 0.0% | 0.01% | +10.0% |
| Q2 2015 | $20,000 | 0.0% | 237 | 0.0% | 0.01% | 0.0% |
| Q1 2015 | $20,000 | 0.0% | 237 | 0.0% | 0.01% | +11.1% |
| Q4 2014 | $20,000 | +25.0% | 237 | +14.5% | 0.01% | +12.5% |
| Q3 2014 | $16,000 | 0.0% | 207 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $16,000 | 0.0% | 207 | 0.0% | 0.01% | 0.0% |
| Q1 2014 | $16,000 | 0.0% | 207 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $16,000 | +60.0% | 207 | +38.0% | 0.01% | +60.0% |
| Q3 2013 | $10,000 | +11.1% | 150 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $9,000 | – | 150 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |